David MacTavish Selected Research

Chronic Pain

1/2006

RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David MacTavish Research Topics

Disease

12	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 02/2002
1	Inflammation (Inflammations) 10/2017
1	Type 2 Diabetes Mellitus (MODY) 05/2012
1	Hypovolemia 05/2006
1	Hypertrophy 02/2006
1	Hyperalgesia 01/2006
1	Chronic Pain 01/2006
1	Pain (Aches) 01/2006

Drug/Important Bio-Agent (IBA)

6	Amyloid (Amyloid Fibrils)IBA 10/2021 - 01/2011
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2004
4	Peptides (Polypeptides)IBA 10/2021 - 05/2005
3	Islet Amyloid PolypeptideIBA 10/2021 - 06/2003
3	Islet Amyloid Polypeptide ReceptorsIBA 10/2021 - 01/2017
3	Amyloid beta-PeptidesIBA 10/2017 - 05/2005
2	Amino Acids FDA Link 08/2007 - 05/2005
2	phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamideIBA 05/2006 - 01/2006
2	GalaninIBA 02/2006 - 02/2002
1	Calcitonin Receptors (Calcitonin Receptor)IBA 10/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2021
1	Amyloidogenic ProteinsIBA 05/2012
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 08/2007
1	Staphylococcal Protein A (Protein A)IBA 08/2007
1	Glutamate Receptors (Glutamate Receptor)IBA 08/2007
1	Vasopressins (Vasopressin)IBA 05/2006
1	NeuropeptidesIBA 02/2006
1	Heroin (Diamorphine)IBA 01/2006
1	Opioid Analgesics (Opioids)IBA 01/2006
1	neuropeptide FF receptorIBA 01/2006
1	Cholinergic Agents (Cholinergics)IBA 02/2002

Therapy/Procedure

1	Therapeutics 01/2017